Health and Healthcare
5864 Articles
According to Credit Suisse, Pfizer investors might be getting to make up some of that relative underperformance of late.
This is one of those mergers that is not getting the warm fuzzy feeling that management teams love to see.
Axsome shares jumped on Wednesday after the firm gave an update from the FDA regarding its AXS-05 for the treatment…
The March 15 short interest data have been compared with the previous figures, and short interest in most of these…
The March 15 short interest data have been compared with the previous report, and short interest in most of the…
Tuesday afternoon, the attorney general of Oklahoma is expected to announce that the state has reached a settlement with Purdue…
The U.S. FDA has proposed new guidelines to address cybersecurity threats to implanted medical devices. Comments on the guidelines are…
Curis shares jumped when the firm announced that it entered into an agreement to sell rights to a portion of…
Biogen shares made a slight gain early on Monday after the firm made an SEC filing indicating that it will…
Neurotrope Inc. (NASDAQ: NTRP) may be a winner by default in the battle against Alzheimer’s disease after shares of Biogen…
Biogen shares were crushed in Thursday’s session after the firm announced that it would be discontinuing its late-stage trial for…
Gene therapy may become the next frontier for drug companies seeking to make billions of dollars improving or even curing…
Pfizer is looking to collaborate with Vivet on the development of its proprietary treatment for Wilson disease.
AbbVie and patients suffering from multiple myeloma have seen some additional bad news from the FDA.
Altimmune shares surged on Tuesday following results from its midstage study of a intranasal influenza vaccine candidate.
Our top personal finance-related articles today. Your wallet will thank you later.